Advertisement
Screener

USANA HEALTH SCIENCES, INC. (USNA) Excess Tax Benefit from Share-based Compensation, Operating Activities

2.8 / 5 stars · 68/120 Roast Me

USANA HEALTH SCIENCES, INC. Excess Tax Benefit from Share-based Compensation, Operating Activities

USANA HEALTH SCIENCES, INC. (USNA) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of $12.02 million for the 12-month period ending 2016-01-02, per its 10-K filed 2018-02-28.

Discontinued › Notes › Compensation Related Costs

us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2018-02-28

  • USANA HEALTH SCIENCES, INC. excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-01-02 was $2.29M, a 78.92% decline year-over-year.
  • USANA HEALTH SCIENCES, INC. excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-10-03 was $4.00M, a 557.31% increase year-over-year.
  • USANA HEALTH SCIENCES, INC. excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-07-04 was $4.83M, a 215.22% increase year-over-year.
  • USANA HEALTH SCIENCES, INC. excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-04-04 was $910.00K, a 50.97% decline year-over-year.
  • USANA HEALTH SCIENCES, INC. excess tax benefit from share-based compensation, operating activities for fiscal 2016 was $12.02M, a 18.94% decline from fiscal 2015.
  • USANA HEALTH SCIENCES, INC. excess tax benefit from share-based compensation, operating activities for fiscal 2015 was $14.83M, a 98.69% increase from fiscal 2013.
  • USANA HEALTH SCIENCES, INC. excess tax benefit from share-based compensation, operating activities for fiscal 2013 was $7.47M, a 116.85% increase from fiscal 2012.
  • USANA HEALTH SCIENCES, INC. excess tax benefit from share-based compensation, operating activities for fiscal 2012 was $3.44M, a 7072.92% increase from fiscal 2011.
Period endExcess Tax Benefit from Share-based Compensation, Operating Activities 3 monthExcess Tax Benefit from Share-based Compensation, Operating Activities 6 monthExcess Tax Benefit from Share-based Compensation, Operating Activities 9 monthExcess Tax Benefit from Share-based Compensation, Operating Activities 12 month
2016-01-02$2.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
$6.29M
derived: sum of 2 quarters · filed 2018-02-28
$11.11M
derived: sum of 3 quarters · filed 2018-02-28
$12.02M
10-K · filed 2018-02-28
2015-10-03$4.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$8.83M
derived: sum of 2 quarters · filed 2016-11-09
$9.74M
10-Q · filed 2016-11-09
$20.58M
derived: sum of 4 quarters · filed 2017-03-01
2015-07-04$4.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$5.74M
10-Q · filed 2016-08-09
$16.57M
derived: sum of 3 quarters · filed 2017-03-01
$17.18M
derived: sum of 4 quarters · filed 2017-03-01
2015-04-04$910.00K
10-Q · filed 2016-05-11
$11.75M
derived: sum of 2 quarters · filed 2017-03-01
$12.36M
derived: sum of 3 quarters · filed 2017-03-01
$13.89M
derived: sum of 4 quarters · filed 2017-03-01
2015-01-03$10.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$11.45M
derived: sum of 2 quarters · filed 2017-03-01
$12.98M
derived: sum of 3 quarters · filed 2017-03-01
$14.83M
10-K · filed 2017-03-01
2014-09-27$609.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
$2.14M
derived: sum of 2 quarters · filed 2015-11-12
$4.00M
10-Q · filed 2015-11-12
$3.89M
derived: sum of 4 quarters · filed 2016-03-01
2014-06-28$1.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12
$3.39M
10-Q · filed 2015-08-12
$3.28M
derived: sum of 3 quarters · filed 2016-03-01
$9.12M
derived: sum of 4 quarters · filed 2016-03-01
2014-03-29$1.86M
10-Q · filed 2015-05-13
$1.75M
derived: sum of 2 quarters · filed 2016-03-01
$7.59M
derived: sum of 3 quarters · filed 2016-03-01
$9.14M
derived: sum of 4 quarters · filed 2016-03-01
2013-12-28-$104.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01
$5.73M
derived: sum of 2 quarters · filed 2016-03-01
$7.28M
derived: sum of 3 quarters · filed 2016-03-01
$7.47M
10-K · filed 2016-03-01
2013-09-28$5.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$7.38M
derived: sum of 2 quarters · filed 2014-11-06
$7.57M
10-Q · filed 2014-11-06
$8.23M
derived: sum of 4 quarters · filed 2015-03-17
2013-06-29$1.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05
$1.73M
10-Q · filed 2014-08-05
$2.40M
derived: sum of 3 quarters · filed 2015-03-17
$4.80M
derived: sum of 4 quarters · filed 2015-03-17
2013-03-30$185.00K
10-Q · filed 2014-05-07
$849.00K
derived: sum of 2 quarters · filed 2015-03-17
$3.25M
derived: sum of 3 quarters · filed 2015-03-17
$3.45M
derived: sum of 4 quarters · filed 2015-03-17
2012-12-29$664.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17
$3.06M
derived: sum of 2 quarters · filed 2015-03-17
$3.27M
derived: sum of 3 quarters · filed 2015-03-17
$3.44M
10-K · filed 2015-03-17
2012-09-29$2.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
$2.60M
derived: sum of 2 quarters · filed 2013-11-07
$2.78M
10-Q · filed 2013-11-07
$2.78M
derived: sum of 4 quarters · filed 2014-03-13
2012-06-30$204.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
$380.00K
10-Q · filed 2013-08-08
$380.00K
derived: sum of 3 quarters · filed 2014-03-13
$380.00K
derived: sum of 4 quarters · filed 2014-03-13
2012-03-31$176.00K
10-Q · filed 2013-05-07
$176.00K
derived: sum of 2 quarters · filed 2014-03-13
$176.00K
derived: sum of 3 quarters · filed 2014-03-13
$189.00K
derived: sum of 4 quarters · filed 2014-03-13
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
$0.00
derived: sum of 2 quarters · filed 2014-03-13
$13.00K
derived: sum of 3 quarters · filed 2014-03-13
$48.00K
10-K · filed 2014-03-13
2011-10-01$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07
$13.00K
derived: sum of 2 quarters · filed 2012-11-07
$48.00K
10-Q · filed 2012-11-07
$1.71M
derived: sum of 4 quarters · filed 2013-03-11
2011-07-02$13.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
$48.00K
10-Q · filed 2012-08-08
$1.71M
derived: sum of 3 quarters · filed 2013-03-11
$2.44M
derived: sum of 4 quarters · filed 2013-03-11
2011-04-02$35.00K
10-Q · filed 2012-05-10
$1.69M
derived: sum of 2 quarters · filed 2013-03-11
$2.42M
derived: sum of 3 quarters · filed 2013-03-11
2011-01-01$1.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11
$2.39M
derived: sum of 2 quarters · filed 2013-03-11
$2.45M
10-K · filed 2013-03-11
2010-10-02$731.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09
$792.00K
10-Q · filed 2011-11-09
2010-07-03$61.00K
10-Q · filed 2011-08-10
2010-01-02$11.00K
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Canopy Growth Corp (CGC)$0.395B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87